We characterized the cross-talk between activators of protein kinase A (PKA) and thyroid hormone (T 3 ) in T 3 receptor (TR)-mediated transcription. U937 cells were cotransfected with a plasmid expressing the TR and a reporter plasmid containing a T 3 response element (TRE) oriented either as a direct repeat or as a palindrome upstream of the thymidine kinase promoter linked to the chloramphenicol acetyltransferase gene. T 3 activated transcription by 10-fold. T 3 response was potentiated 2.5-3-fold by activators of PKA, but an activator of protein kinase C or of guanylate kinase was ineffective. In the absence of T 3 , activators of PKA had no effect on transcription. TR heterodimerization with the retinoid X receptor may facilitate T 3 /PKA cross-talk because coexpression of the retinoid X receptor potentiated cross-talk. Synergy was not observed in JEG-3, F9, CV-1, HeLa, L929, and HTC cells, indicating that it may require cell-specific factors. Synergy required the DNAand ligand-binding domains, but not the amino-terminal domain, indicating that T 3 -and TRE-induced conformational changes on the TR are essential for cross-talk. PKA phosphorylated the TR in vitro, suggesting that, like other nuclear receptors, the TR is a target for PKA. These results imply that PKA cross-talks with T 3 at the level of the TRE-bound TR, enhancing its transcriptional activity in a cell-specific manner.Thyroid hormones promote diverse actions on development and differentiation of many tissues in vertebrates by binding to thyroid hormone (T 3 ) 1 receptors (TRs) (1). TRs are one of the ligand-regulated transcription factors in the nuclear receptor superfamily that includes receptors for steroids, vitamins, peroxisomal proliferators, and "orphan" receptors for which no ligands have been identified (2-6). Two genes code for TRs, but differential RNA splicing or promoter usage generates four isoforms: TR␣1, TR␣2, TR1, and TR2 (3, 5, 6). Like other nuclear receptor superfamily members, TRs contain three major modular domains (2-6). The amino-terminal domain is presumably involved in transcriptional activation. The DNAbinding domain (DBD) directs receptor binding to specific thyroid hormone response elements (TREs), where TRs bind as monomers, homodimers, or heterodimers commonly with retinoid X receptors (RXRs) (7,8). The ligand-binding domain (LBD) binds T 3 and participates in other functions such as dimerization and transcriptional activation or repression (2-6).The actions of nuclear receptors are known to be influenced by second messenger signaling systems such as those that affect the activity of adenylate cyclase/3Ј,5Ј-cAMP-dependent protein kinase (PKA) and phospholipase/protein kinase C (PKC) (9 -13). Thus, PKA enhances ligand-dependent transcriptional activation of glucocorticoid, retinoic acid (RAR), estrogen, progesterone, and vitamin D receptors (11, 14 -19). PKA has also been shown to phosphorylate the RAR (16,17) and the progesterone receptor (20). Phosphorylation of nuclear receptors has been directly implicated in ...